{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:43:21Z","timestamp":1782366201154,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","award":["SPI 94- 212"],"award-info":[{"award-number":["SPI 94- 212"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["833247"],"award-info":[{"award-number":["833247"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126396","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:49:33Z","timestamp":1727671773000},"page":"126396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination"],"prefix":"10.1016","volume":"42","author":[{"given":"Lisa U.","family":"Teufel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther J.M.","family":"Taks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"van Gemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Neacsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"F\u00f6hse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Diavatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.W.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126396_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126396_bb0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2024.126396_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-020-00806-z","article-title":"The interplay between immunosenescence and age-related diseases","volume":"42","author":"Barbe-Tuana","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12979-023-00348-6","article-title":"Targeting the hallmarks of aging to improve influenza vaccine responses in older adults","volume":"20","author":"Cadar","year":"2023","journal-title":"Immun Ageing"},{"key":"10.1016\/j.vaccine.2024.126396_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155824","article-title":"Interleukin-38 in health and disease","volume":"152","author":"de Graaf","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2024.126396_bb0035","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126396_bb0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/JLB.3A0220-143RRR","article-title":"IL-38 prevents induction of trained immunity by inhibition of mTOR signaling","volume":"110","author":"de Graaf","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032311","article-title":"Opposing effects of interleukin-36gamma and Interleukin-38 on trained immunity","volume":"24","author":"Teufel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.126396_bb0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/107999001753289505","article-title":"Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14","volume":"21","author":"Bensen","year":"2001","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.vaccine.2024.126396_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2024.126396_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: structure, signaling and function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0065","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2024.126396_bb0070","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2024.126396_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/vaccines7020042","article-title":"Designed DNA-encoded IL-36 gamma acts as a potent molecular adjuvant enhancing Zika synthetic DNA vaccine-induced immunity and protection in a lethal challenge model","volume":"7","author":"Louis","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126396_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156268","article-title":"Cytokines and their role as immunotherapeutics and vaccine adjuvants: the emerging concepts","volume":"169","author":"Rahman","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2024.126396_bb0085","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2024.126396_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.vaccine.2024.126396_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-60761-585-9_19","article-title":"Adjuvant activity of cytokines","volume":"626","author":"Tovey","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0264-410X(92)90389-2","article-title":"Cytokines as immunological adjuvants","volume":"10","author":"Heath","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126396_bb0105","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jiad392","article-title":"Analysis of the immunostimulatory effects of cytokine-expressing internal ribosome entry site\u2013based RNA adjuvants and their applications","volume":"229","author":"Lee","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126396_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065676","article-title":"Cell intrinsic IL-38 affects B cell differentiation and antibody production","volume":"24","author":"Huard","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.126396_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-022-00438-4","article-title":"BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial","volume":"7","author":"Gillard","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126396_bb0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-1759(03)00231-X","article-title":"Simple and cost-effective isolation of monocytes from buffy coats","volume":"278","author":"Repnik","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2024.126396_bb0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201142035","article-title":"Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9","volume":"42","author":"Mutamba","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964365","article-title":"Circulating interleukin-38 concentrations in healthy adults","volume":"13","author":"Teufel","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0140","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.126396_bb0150","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: a review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126396_bb0155","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/exd.14644","article-title":"IL-38 orchestrates proliferation and differentiation in human keratinocytes","volume":"31","author":"Mermoud","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40259-023-00587-5","article-title":"Targeting IL-36 in inflammatory skin diseases","volume":"37","author":"Fukaura","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2024.126396_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738123","article-title":"Characterising the phenotypic diversity of antigen-specific memory B cells before and after vaccination","volume":"12","author":"Tjiam","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126396_bb0170","first-page":"395","article-title":"Cross-reactions between Bordetella pertussis and twenty-eight other bacterial species","volume":"84B","author":"Hoiby","year":"1976","journal-title":"Acta Pathol Microbiol Scand B"},{"key":"10.1016\/j.vaccine.2024.126396_bb0175","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:21:24Z","timestamp":1777537284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010788"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126396","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126396"}}